Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised Phase II study of carboplatin with or without ZD4054 in metastatic breast cancer
2010-018837-23Phase 2Terminated
- Sponsor
- Cardiff University
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of zibotentan in breast cancer (2 arms), sponsored by Cardiff University. Primary endpoint: Progression-Free Survival. Started Oct 2010; status: terminated.
02
Drugs
zibotentan
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2010-018837-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018837-23.